| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 May 2025 | 8 May 2025 |
| Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve 1. the Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 2. To Recommend Dividend If Any 3. an appointment of Secretarial Auditor for the Financial Year 2025-26 subject to approval of shareholders 4. An appointment of Internal Auditor for the FY 2025-26 5. an appointment of Cost Auditor for the FY 2025-26. 6. To fix the date time and venue for the 44th Annual General Meeting and approve the draft notice of the 44th Annual General Meeting of the Company. 7. any other items of Agenda if any Outcome of Board Meeting Held On May 14, 2025 is attached Intimation for appointment of an internal, secretarial & Cost auditors is attached (As Per BSE Announcement dated on 14.05.2025) | ||
| Board Meeting | 12 Feb 2025 | 5 Feb 2025 |
| Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve Unaudited Financial Results For The Quarter And nine months Ended On December 31 2024 Outcome of Board Meeting for approval of Unaudited Financial results for the quarter and nine months ended on December 31, 2024 is attached (As per BSE Announcement Dated on 12/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 7 Nov 2024 |
| Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited financial results for the quarter and half year ended on September 30 2024 In the attached revised outcome corrected misprint of EPS numbers In attached revised results corrected misprint of EPS numbers (As Per BSE Announcement Dated on 15.11.2024) | ||
| Board Meeting | 24 Jul 2024 | 17 Jul 2024 |
| Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve 1. the Unaudited Financial Results of the Company for the quarter ended on June 30 2024. 2.To decide the date time and venue of 43rd Annual General Meeting of the Company 3.notice convening 43rd Annual General Meeting of the Members of the Company. 4. Any other items of Agenda if any Unaudited Financial Results for the Quarter Ended on June-2024 is attached Announcement under Reg 30(LODR)-Change in Director Outcome of Board Meeting held on July 24, 2024 is attached (As per BSE Announcement Dated on 24/07/2024) In attached revised outcome corrected NRC committee constitution in annexure (As Per BSE Announcement Dated on 26.07.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.